Aytu BioPharma, Inc. (AYTU)

Aytu BioPharma Revenue

Aytu BioPharma had revenue of $13.89M in the quarter ending September 30, 2025, a decrease of -16.21%. This brings the company's revenue in the last twelve months to $63.70M, down -0.38% year-over-year. In the fiscal year ending June 30, 2025, Aytu BioPharma had annual revenue of $66.38M with 1.84% growth.

• Revenue (ttm): $63.70M
• Revenue Growth: -0.38%
• P/S Ratio: 0.29
• Revenue / Employee: $767,422
• Employees: 83
• Market Cap: 26.49M

Revenue History

Fiscal Year End	Revenue	Change	Growth
Jun 30, 2025	66.38M	1.20M	1.84%
Jun 30, 2024	65.18M	-42.22M	-39.31%
Jun 30, 2023	107.40M	10.73M	11.10%
Jun 30, 2022	96.67M	31.04M	47.29%
Jun 30, 2021	65.63M	38.00M	137.52%
Jun 30, 2020	27.63M	-	-
Jun 30, 2019	-	-	-
Jun 30, 2018	3.66M	-2.78M	-43.19%
Jun 30, 2017	6.44M	-	-
Jun 30, 2016	-	-	-
Jun 30, 2015	261.78K	260.78K	26,078.20%
Aug 31, 2014	1,000.00	-57.93K	-98.30%
Jun 30, 2014	58.93K	57.18K	3,267.37%
Aug 31, 2013	1.75K	-48.25K	-96.50%
Jun 30, 2013	50.00K	48.25K	2,757.14%
Aug 31, 2012	1.75K	-	-
Aug 31, 2011	-	-	-
Aug 31, 2010	-	-	-
Aug 31, 2009	1.75K	-	-
Aug 31, 2008	-	-	-
Aug 31, 2007	-	-	-